XC
RDY icon

XY Capital’s Dr. Reddy's Laboratories RDY Stock Holding History

XY Capital’s Portfolio RDY Stock Details RDY Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q4 		– Sell
-22,064
Closed -$308K – 304
2025
Q3 		$308K Sell
22,064
-60,664
-73% -$873K 0.16% 92
2025
Q2 		$1.24M Buy
82,728
+63,039
+320% +$900K 0.86% 22
2025
Q1 		$260K Sell
19,689
-47,520
-71% -$656K 0.07% 159
2024
Q4 		$1.06M Buy
+67,209
New +$1.01M 0.51% 56

Other funds holding RDY

Robeco Institutional Asset Management
Robeco Institutional Asset Management Rotterdam, Netherlands $81.4B AUM 40.71% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Royal Bank of Canada
Royal Bank of Canada Toronto, Ontario, Canada $570B AUM 27.57% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
AIM
Aikya Investment Management London, United Kingdom $345M AUM 10.59% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BNP Paribas Financial Markets
BNP Paribas Financial Markets Paris, France $206B AUM 31.61% 1-Year Est. Return

XY Capital's RDY Position: Q4 2025 in Review

XY Capital sold out of Dr. Reddy's Laboratories (RDY) in Q4 2025, closing a stake of 22,064 shares — an estimated $308K sold.

XY Capital first reported a position in RDY in Q4 2024 and held it in 4 quarters. The position peaked at $1.24M in Q2 2025. 235 funds tracked by Wall St. Rank hold RDY as of Q4 2025.

  • XY Capital reported no remaining Dr. Reddy's Laboratories position as of Q4 2025 after selling out during the quarter.
  • XY Capital sold 22,064 Dr. Reddy's Laboratories shares in Q4 2025, an estimated $308K.
  • XY Capital first reported a position in Dr. Reddy's Laboratories in Q4 2024 and held it in 4 quarters.
  • XY Capital's Dr. Reddy's Laboratories position peaked at $1.24M in Q2 2025.
  • 235 funds tracked by Wall St. Rank held Dr. Reddy's Laboratories as of Q4 2025.

Based on XY Capital's 13F filing for Q4 2025, filed 12 Feb 2026.